Back | Next |
home / stock / dyai / dyai message board
Subject | By | Source | When |
---|---|---|---|
$DYAI oh yeah news for the day | jfk | investorshub | 04/02/2023 8:20:23 AM |
The gaining | blue_skies | investorshub | 04/02/2023 7:45:15 AM |
$DYAI great news | Paullee | investorshub | 04/02/2023 2:34:39 AM |
Price now | blue_skies | investorshub | 04/02/2023 2:19:12 AM |
MomentumIts gaining last trade up | Paullee | investorshub | 04/02/2023 1:55:47 AM |
Price now | Paullee | investorshub | 04/02/2023 12:01:07 AM |
$DYAI and the shorts continue | Paullee | investorshub | 04/01/2023 11:53:27 PM |
$DYAI short squeeze signal | jfk | investorshub | 04/01/2023 9:46:26 PM |
What do you make of this? | Paullee | investorshub | 04/01/2023 5:28:36 PM |
bears are running | natec22 | investorshub | 04/01/2023 8:38:07 AM |
$DYAI The gaining | natec22 | investorshub | 04/01/2023 5:43:57 AM |
$DYAI Price now last trade up | natec22 | investorshub | 04/01/2023 3:17:31 AM |
The now | blue_skies | investorshub | 03/31/2023 11:55:59 PM |
$DYAI where is the squeeze? | blue_skies | investorshub | 03/31/2023 10:56:56 PM |
Price gaining last up | blue_skies | investorshub | 03/31/2023 8:45:07 PM |
The trading last trade up | Paullee | investorshub | 03/31/2023 12:57:23 PM |
Price now | Paullee | investorshub | 03/31/2023 11:39:57 AM |
$DYAI Found an interesting article | Paullee | investorshub | 03/31/2023 10:23:23 AM |
$DYAI good read | Paullee | investorshub | 03/31/2023 8:46:35 AM |
$DYAI The gaining | blue_skies | investorshub | 03/31/2023 7:58:13 AM |
News, Short Squeeze, Breakout and More Instantly...
Dyadic International Inc. Company Name:
DYAI Stock Symbol:
OTCMKTS Market:
Dyadic International Inc. Website:
JUPITER, Fla., June 28, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI), announced today that they have entered into a development and commercialization partnership with Proliant Health and Biologicals (PHB), a leading supplier of purified proteins for ...
JUPITER, Fla., May 30, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and animal vaccines and therapeutics, as well a...
Human Health Sector Final Clinical Study Report has been issued for the First-In-Human Phase 1 clinical trial demonstrating safety and antibody response for DYAI-100, a recombinant protein receptor binding domain booster vaccine candidate for protection against C...